Waters Corporation (WAT)
NYSE: WATIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Nov 20, 4:01 PM ET · Delayed 15 min
WAT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $86.56B
- P/E (TTM)
- 184.29
- Forward P/E
- 26.65
- EPS (TTM)
- $2.39
- Dividend yield
- None
- 52-week range
- 282.77 – 483.33
- Day range
- 437.54 – 455.14
- Volume / Avg
- 1.35M / 826.62K
- Beta
- —
- Shares outstanding
- 98.29M
52-week range
WAT stock today
Shares of Waters (WAT) finished lower on Nov 20 at $440.45, a drop of 3.51% or $16.03 per share, versus the S&P 500's 3.70% decline. At this level, WAT sits in the middle of its 52-week range of $282.77 to $483.33: 8.9% below the high, set on Nov 11, 2026 and 55.8% above the low. WAT is up 16.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 11.8%.
At 184.3x trailing earnings, Waters trades above the peer-group median of 33.6x. Its forward P/E of 26.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Waters
Company profileWaters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- CEO
- Dr. Udit Batra Ph.D.
- Headquarters
- Milford, MA
- Employees
- 15,000
- IPO year
- 1995
- Website
- waters.com
Financial highlights
Full financialsIn fiscal 2025, Waters generated $3.17 billion in revenue, up 7.0% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $642.6 million (+0.8% year over year), for a net margin of 20.3% versus a median of 22.1% in the prior 5 years. Gross margin was 59.3% (down from 59.4%) and operating margin 25.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $3.17B | $2.96B | $2.96B | $2.97B | $2.79B |
| Growth | +6.99% | +0.07% | -0.52% | +6.68% | +17.78% |
| Net income | $642.63M | $637.83M | $642.23M | $707.75M | $692.84M |
| EPS (diluted) | $10.76 | $10.71 | $10.84 | $11.73 | $11.17 |
Analyst forecast
ForecastConsensus (24 analysts)
buy
Avg. price target
$503.29+14.27%
- Strong buy 3
- Buy 15
- Hold 5
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $3.40 vs $3.99
- Surprise
- -14.79%
WAT news
All WAT news- Nvidia a new short call at Muddy WatersSeeking AlphaWAT, NVDA
- Muddy Waters shorts Nvidia, raises questions about possible executive connectionInvesting.comWAT, NVDA
- Waters Gains FDA Clearance for Flow Cytometry Tests for Blood CancersNasdaqWAT, ISRG, WST, GKOS
- Waters' BD OneFlow Tests Clear FDA Review; U.S. Launch Set For Spring 2027Nasdaq
- Waters Expands Proteomics Reach With MOBILion Systems AcquisitionNasdaqWAT, ISRG, WST, GKOS
- Waters Q3 Earnings Call HighlightsNasdaq
- Stocks Supported by Strength in ChipmakersNasdaqANET, AAPL, AVGO, BE
- Waters Q3 Earnings & Revenues Beat Estimates, 2026 Guidance RaisedNasdaqWAT, MMSI, OPK, GMED
Waters peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AAgilent Technologies Inc. | 170.38 | -2.83% | $48.04B | vs WAT |
| MTDMettler-Toledo International Inc. | 1,666.88 | -2.27% | $33.15B | vs WAT |
| RVTYRevvity Inc. | 145.22 | -4.20% | $16.21B | vs WAT |
| AVTRAvantor Inc. | 14.84 | -1.85% | $10.06B | vs WAT |
| BIOBio-Rad Laboratories Inc. Class A | 358.90 | -2.34% | $9.65B | vs WAT |
| BRKRBruker Corporation | 56.46 | -9.08% | $8.62B | vs WAT |
| TXG10x Genomics Inc. Class A | 51.80 | -9.72% | $6.81B | vs WAT |
| ALMRAlamar Biosciences Inc. | 26.48 | -7.67% | $1.84B | vs WAT |
Indexes, lists and sector
Index membership
Waters stock FAQ
What is Waters's stock price today?
WAT last traded at $440.45 as of Nov 20, 4:01 PM EST, down 3.51% on the day. Prices are delayed at least 15 minutes.
Does Waters pay a dividend?
No. Waters does not currently pay a regular cash dividend.
What is WAT's P/E ratio?
WAT trades at a trailing P/E ratio of 184.29 and a forward P/E of 26.65, compared with a median of 33.6 for its closest peers.
Is Waters in the S&P 500?
Yes. Waters (WAT) is a constituent of the S&P 500 index.
Who is Waters's CEO?
Dr. Udit Batra Ph.D. is the chief executive officer of Waters Corporation, which has about 15,000 employees.
Has WAT ever split its stock?
Yes. The most recent WAT stock split was a 2-for-1 split on Aug 28, 2000, one of 2 splits on record.
What is the WAT 52-week high?
The 52-week high for WAT is $483.33 and the 52-week low is $282.77. The stock is currently 8.9% below its high.